Merontos, Menzl Mae V.
HRN: 13 21 16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
CEFUROXIME 500MG (TAB)
05/28/2023
06/03/2023
PI
500mg
BID
Uti
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes